Recombinant Human Erythropoietin Injection Market to Grow at 3.8%...

added blog Other

2026-03-13 12:27:44

Recombinant Human Erythropoietin Injection Market to Grow at 3.8% CAGR by 2032

According to a newly published market research report by 24LifeSciences, the global recombinant human erythropoietin injection market was valued at USD 7.6 billion in 2024 and is projected to reach USD 10.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2032. Recombinant human erythropoietin (rhEPO) injection is a critical...

0 Comments 0 Shares 19 Views 0 Reviews